Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

Lionel Kankeu Fonkoua

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

ACG 2023 Conference Coverage

R. Wong

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES…

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

2L Systemic Therapy for Unresectable HCC

Lorenza Rimassa

HCC: Updates in Management

Stanford Medicine

R. Dhanasekaran

GI Oncology Year in Review: Hepatobiliary Cancers

Yale Cancer Center

P. Kunz

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker